Dianthus Therapeutics, Inc. /DE/ (DNTH) Market Cap
- 2026-09-03: Market Cap $6.03B.
- 2026-08-03: Market Cap $5.93B.
- 2026-06-30: Market Cap $5.34B.
- 2026-05-01: Market Cap $4.78B.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2018-06-30 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|
| 2026-09-03 | $6.03B |
|---|
| 2026-08-03 | $5.93B |
|---|
| 2026-06-30 | $5.34B |
|---|
| 2026-05-01 | $4.78B |
|---|
| 2026-03-31 | $4.58B |
|---|
| 2026-03-04 | $2.76B |
|---|
| 2025-12-31 | $1.78B |
|---|
| 2025-11-03 | $1.46B |
|---|
| 2025-09-30 | $1.69B |
|---|
| 2025-08-06 | $656.32M |
|---|
| 2025-06-30 | $599.45M |
|---|
| 2025-05-07 | $642.23M |
|---|
| 2025-03-31 | $582.76M |
|---|
| 2025-03-07 | $771.97M |
|---|
| 2024-12-31 | $678.31M |
|---|
| 2024-11-05 | $850.91M |
|---|
| 2024-09-30 | $804.05M |
|---|
| 2024-08-06 | $828.67M |
|---|
| 2024-06-30 | $759.63M |
|---|
| 2024-05-06 | $702.04M |
|---|
| 2024-03-31 | $880.46M |
|---|
| 2024-03-14 | $788.55M |
|---|
| 2023-12-31 | $154.1M |
|---|
| 2023-11-09 | $169.07M |
|---|
| 2023-09-30 | $202.56M |
|---|
| 2023-07-31 | $776.51M |
|---|
| 2023-06-30 | $737.53M |
|---|
| 2023-04-30 | $756.9M |
|---|
| 2023-03-31 | $766.6M |
|---|
| 2023-01-31 | $533.63M |
|---|
| 2022-12-31 | $5.6M |
|---|
| 2022-10-31 | $1.25B |
|---|
| 2022-09-30 | $1.37B |
|---|
| 2022-07-31 | $1.51B |
|---|
| 2022-06-30 | $1.13B |
|---|
| 2022-04-30 | $1.35B |
|---|
| 2022-03-31 | $2.73B |
|---|
| 2022-01-31 | $3.08B |
|---|
| 2021-12-31 | $4.17B |
|---|
| 2021-10-31 | $6.02B |
|---|
| 2021-09-30 | $6.85B |
|---|
| 2021-07-31 | $6.67B |
|---|
| 2021-06-30 | $9.16B |
|---|
| 2021-04-30 | $9.06B |
|---|
| 2021-03-31 | $9.21B |
|---|
| 2021-01-31 | $6.87B |
|---|
| 2020-12-31 | $6.09B |
|---|
| 2020-10-31 | $4.88B |
|---|
| 2020-09-30 | $5.25B |
|---|
| 2020-07-31 | $5.42B |
|---|
| 2020-06-30 | $5.8B |
|---|
| 2020-04-30 | $5.15B |
|---|
| 2020-03-31 | $3.96B |
|---|
| 2020-01-31 | $7.48B |
|---|
| 2019-12-31 | $9.52B |
|---|
| 2019-10-31 | $6.49B |
|---|
| 2019-09-30 | $6.39B |
|---|
| 2019-07-31 | $8.38B |
|---|
| 2019-06-30 | $9.14B |
|---|
| 2019-04-30 | $7.76B |
|---|
| 2019-03-31 | $8.85B |
|---|
| 2019-02-28 | $7.02B |
|---|
| 2018-12-31 | $3.04B |
|---|
| 2018-10-31 | $4.65B |
|---|
| 2018-09-30 | $6.36B |
|---|
| 2018-07-31 | $7.25B |
|---|
| 2018-06-30 | $7.1B |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|